Hexachlorophene in the newborn nursery. A risk-benefit analysis and review.
A critical review of the available data on the risks and benefits of hexachlorophene suggests that there is ample evidence fror the toxic potential; whereas there is no substantial evidence of its benefit in life-threatening staph 80/81 epidemics, and effective less toxic alternatives are available. In view of its limited usefulness and definite toxicity, the routine use of hexachlorphene is unjustified;
D000818:Animals; D001494:Baths; D002493:Central Nervous System Diseases / Q000139:chemically induced; D004196:Disease Outbreaks / Q000517:prevention & control; D006582:Hexachlorophene / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use / Q000633:toxicity; D006801:Humans; D007224:Infant Care; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000517:prevention & control; D009725:Nurseries, Hospital; D012306:Risk; D012869:Skin Absorption; D013203:Staphylococcal Infections / Q000517:prevention & control; D014481:United States; D014486:United States Food and Drug Administration
D006582:Hexachlorophene